The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.

Schultz, Nina Haagenrud; Tran, Hoa Thi Tuyet; Bjørnsen, Stine; Henriksson, Carola Elisabeth; Sandset, Per Morten; Holme, Pål Andre

Schultz, Nina Haagenrud; Tran, Hoa Thi Tuyet; Bjørnsen, Stine; Henriksson, Carola Elisabeth; Sandset, Per Morten; Holme, Pål Andre.

Afiliação

Schultz NH; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.
Tran HTT; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.
Bjørnsen S; Department of Haematology, Akershus University Hospital, N-1478 Lørenskog, Norway.
Henriksson CE; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway.
Sandset PM; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.
Holme PA; Department of Haematology, Akershus University Hospital, N-1478 Lørenskog, Norway.

Thromb J ; 15: 6, 2017.

Article em En | MEDLINE | ID: mdl-28239301

Palavras-chave

Activated prothrombin complex concentrate; Prothrombin complex concentrate; Recombinant aFVIIa; Reversal; Rivaroxaban

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Thromb J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google